While TBE is listed as a “communicable disease” in the EU since 2012, each country implements reporting nationally with own resources and methods. In most instances, reporting of TBE cases is based on passive surveillance, and thus largely depend on disease awareness with physicians and on availability, cost and use of serological tests for TBE diagnosis. Systematic, regular use of TBE serology in the appropriate clinical setting is in place in few countries only, despite the fact that it would be a necessary prerequisite to gain reliable data on the true incidence of TBE in a given country. The scientific appropriate methodology would be to document that >80% of subjects with meningitis / encephalitis are tested for TBE in an endemic region. As this is not accomplished anywhere, the data shown for individual countries in chapter 12b are 1) not necessarily comparable to each other and 2) underestimate the real burden of disease and indicate just the minimum number of cases.
(Please, click on the country you are interested in.)
• Bosnia and Herzegovina
• Czech Republic
• South Korea
• Switzerland and Liechtenstein
• United Kingdom